QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 293 filers reported holding QIAGEN NV in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C M BIDWELL & ASSOCIATES LTD | 301,504 | $8,448,000 | 1.99% |
| PRIMECAP MANAGEMENT CO/CA/ | 19,143,036 | $536,388,000 | 0.53% |
| Granahan Investment Management | 535,700 | $15,010,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,704,116 | $47,749,000 | 0.37% |
| BALYASNY ASSET MANAGEMENT L.P. | 914,759 | $25,608,000 | 0.14% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 626,250 | $17,548,000 | 0.02% |
| BALYASNY ASSET MANAGEMENT L.P. | 153,700 | $4,303,000 | 0.02% |
| Capital Research Global Investors | 2,259,565 | $63,393,000 | 0.02% |
| RHUMBLINE ADVISERS | 201,388 | $5,643,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 16,373 | $459,000 | 0.01% |